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Abstract
Background: Paraplegia remains a potential complication of spinal cord ischemic reperfusion injury (IRI) in which 
oxidative stress induced cyclooxygenase activities may contribute to ischemic neuronal damage. Prolonged 
administration of vitamin E (α-TOL), as a potent biological antioxidant, may have a protective role in this oxidative 
inflammatory ischemic cascade to reduce the incidence of paraplegia. The present study was designed to evaluate the 
preventive value of α-TOL in IRI of spinal cord.
Methods: For this study, 50 male Sprague-Dawley rats were used and divided into five experimental groups (n = 10): 
Control group (C); α-TOL control group (CE) which received intramuscular (i.m.) α-TOL injections (600 mg/kg); Sham 
operated group (S), IRI rats were subjected to laparotomy and clamping of the aorta just above the bifurcation for 45 
min, then the clamp was released for 48 hrs for reperfusion; and IRIE rats group, received 600 mg/kg of α-TOL i.m. twice 
weekly for 6 weeks, followed by induction of IRI similar to the IRI group. At the end of the experimental protocol; motor, 
sensory and placing/stepping reflex evaluation was done. Plasma nitrite/nitrate (NOx) was measured. Then animals' 
spinal cord lumbar segments were harvested and homogenized for measurement of the levels of prostaglandin E2 
(PGE2), malondialdehyde (MDA) and advanced oxidation products (AOPP), while superoxide dismutase (SOD) and 
catalase (CAT) activity were evaluated.
Results: Induction of IRI in rats resulted in significant increases in plasma levels of nitrite/nitrate (p < 0.001) and spinal 
cord homogenate levels of PGE2, MDA, advanced oxidation protein products AOPP and SOD with significant reduction 
(p < 0.001) in CAT homogenate levels. Significant impairment of motor, sensory functions and placing/stepping reflex 
was observed with IRI induction in the spinal cord (p < 0.001). α-TOL administration in IRIE group significantly improved 
all the previously measured parameters compared with IRI group.
Conclusions: α-TOL administration significantly prevents the damage caused by spinal cord IRI in rats with subsequent 
recovery of both motor and sensory functions. Alpha-tocopherol improves the oxidative stress level with subsequent 
reduction of the incidence of neurological deficits due to spinal cord IRI conditions.
Background
Ischemic reperfusion injury (IRI) of the spinal cord
occurs due to temporary interruption of the blood supply
to the spinal cord. This may result in irreversible vascular
injuries with subsequent paraplegia or other neurological
deficits [1]. This serious complication is frequently seen
in transient ischemic insults of the spinal cord and after
surgical repair of thoraco-abdominal aortic aneurysms
[2]. Oxidative stress with over-production of reactive
oxygen species (ROS), such as free radicals and peroxides
are incriminated in the neurological vascular injuries [3].
Increased ROS in dorsal horn neurons may contribute to
central sensitization in neuropathic rats [4]. Overproduc-
tion of ROS and oxygen free radicals in ischemic reperfu-
sion conditions may also lead to excessive lipid
peroxidation and protein and DNA damage [5]. In rats,
w i t h  l i g a t i o n  o f  s c i a t i c  n e r v e ,  s u p e r o x i d e  d i s m u t a s e
(SOD) and glutathione peroxidase (GPx) activities
increase, while catalase (CAT) activity decrease signifi-
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cantly due to associated oxidative stress and reduction of
antioxidant defense potential [6]. In addition, Regan and
Guo [7] reported that prolonged depletion of glutathione
in the brain is associated with oxidative neuronal death.
Ischemia induces oxidative stress, leading to induction
and expression of various genes in a variety of cell types
throughout the central nervous system [8]. One of these
important genes is the cyclooxygenase enzyme gene. This
enzyme is the rate-limiting enzyme involved in arachi-
donic acid metabolism, with subsequent generation of
prostaglandins and thromboxanes that play important
roles in sustaining the inflammatory response and induce
different neurological deficits [9]. Elements of oxidative
stress appeared to be essential for the activation of this
enzyme [10]. Oxidative stress induces cyclooxygenase-2
(COX-2) activity in neurons after various CNS insults,
including global ischemia [11].
The COX-2 inhibitors as SC-58125 and NS-398 have
been shown to prevent delayed death of hippocampal
neurons [12] and to reduce infarct size after global isch-
emia [13]. Vitamin E (α-tocopherol) is an important lipid-
soluble chain-breaking antioxidant, essential to scavenge
ROS in tissues, red cells, and plasma [14]. α-tocopherol
(α-TOL) significantly reduces induced nitric oxide syn-
thase enzyme (iNOS) activity and cyclic glutamate mono-
phosphate (cGMP) levels in diabetic rats [15]. α-TOL,
which is the predominant form of vitamin E in clinical
uses, has been found to attenuate COX-2 activity by scav-
enging the oxidant hydroperoxide that acts as activator
for COX-2 enzyme with subsequent suppression of pros-
taglandin E2 (PGE2) production [16]. Other experiments
demonstrated that α-TOL decreases COX-2 activity
through reduction of peroxynitrite formation necessary
for its activation [17]. Another mechanism through
which α-TOL reduces PGE2 production could be through
direct inhibition of COX activity without affecting COX
mRNA and its protein levels, indicating a post-transla-
tional regulation of COX [18].
Most of the carried studies in this field were con-
structed for short-term administration of the therapeutic
agents just before or after IRI, while our study could be
one of the recent studies for long-term prophylactic
administration of α-TOL on IRI of the spinal cord.
So, the aim of the present study is to explore the possi-
ble prophylactic effect of long-term administration of α-
TOL in spinal cord reperfusion injury against high oxida-
tive stress induced by ischemia; and to investigate the role
of α-TOL in the inhibition of COX-2 activity, with subse-
quent suppression of inflammatory PGE2 over-produc-
tion.
Methods
Animals and their groups
This study followed a randomized controlled animal
experiment design. A total of 50 male Sprague-Dawley
rats were randomized into 5 study groups. All rats were
obtained from the National Research Center, Cairo,
Egypt and weighed between 150 and 200 gm. Animals
were fed on a standard chow diet, water, ad libitum and
housed in the animal house of Menoufiya College of
Medicine with a 12:12-hrs light/dark cycle. The animals
were randomly divided into five groups (n = 10 each) as
follows: C rats which underwent no surgery; CE animals
received α-TOL 600 mg/kg i.m. twice weekly [19]; S
(sham) rats were subjected to laparotomy without clamp-
ing of the aorta; IRI rats were subjected to laparotomy
and clamping the aorta by non-traumatic vascular clamp
just above the bifurcation for 45 min, then the clamp was
released for reperfusion for 48 hrs; and IRIE rats were
injected i.m. with α-TOL by the same dose and maneuver
as rats in the CE group then IRI was induced as in IRI
group. Control rats were injected i.m. with vehicle alone.
The experiments were conducted in accordance with the
ethical guidelines for investigations in laboratory animals
and were approved by the Ethical Committee of the Col-
lege of Medicine, Menoufiya University.
Induction of ischemic reperfusion injury of the spinal cord
Spinal cord ischemia was induced, as described by
Akguna et al. [20]. Rats were initially anesthetized with
i.m. ketamine (50 mg/kg), followed by a half dose as
required during the procedure. The animals did not
receive ventilatory support. Body temperature was moni-
tored by a rectal probe inserted into the rectum and was
maintained between 37°C and 38°C by a thermal pad and
a heating lamp. The femoral artery was cannulated with a
22-gauge PE catheter, which was used to monitor distal
arterial pressure (DAP) and for intra-arterial infusion of
heparin. The left carotid artery was cannulated with a 20-
gauge PE catheter (Terumo, Tokyo, Japan), which was
used to monitor the proximal artery pressure (PAP) and
to take blood samples. Each rat received 150 IU/kg hepa-
rin injected into the femoral artery immediately after
completion of arterial cannulation and before aortic
occlusion. The abdominal aorta was reached through
midline laparotomy. Animals in sham group (group S)
were anesthetized and subjected to laparotomy without
aortic occlusion. In IRI and IRIE groups, animals were
subjected to aortic cross clamping for 45 minutes. Vascu-
lar clamps were placed under the left renal vein and above
the bifurcation of the aorta. The efficiency of occlusion
was documented by an immediate and sustained
decrease in DAP in the femoral artery. To maintain the
PAP approximately at 40 mmHg during occlusion, blood
from the carotid artery was allowed to flow into a collect-
ing circuit filled with heparinized saline (4 U/ml of saline)
positioned 54 cm above the rat. The temperature of the
blood in the syringe was maintained at 37- 37.5°C. The
aortic clamps were released after 45 min and the blood in
the syringe was transfused back into the rat over a 60-secMorsy et al. Journal of Biomedical Science 2010, 17:55
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period. After completion of all procedures, the wounds
were closed. Protamine sulfate (4 mg) was subcutane-
ously injected to reverse the anticoagulation effect of
heparin. Animals were allowed to recover in a plastic box
at 28°C for 3 hours and were then placed in their cages
with free access to food and water [21]. Rats with com-
plete hind limb paralysis for 24 hours, hematuria, or 25%
reduction in body weight were killed by using a lethal
dose of thiopental sodium injection (75 mg/kg i.p.) for
humanitarian reasons [22].
Neurological assessment
Hind limbs neurologic function was assessed at 48 hours
after the procedure using the Tarlov Scoring System [23].
A score of 0-5 was assigned to each animal as follows: 0 =
no voluntary hind limb movement; 1 = movement of
joints perceptible; 2 = active movement but unable to sit
without assistance; 3 = able to sit but unable to hop; 4 =
weak hop; 5 = complete recovery of hind limb function.
The placing/stepping reflex (SPR) was assessed by drag-
ging the dorsum of the hind paw along the edge of a sur-
face. This normally evokes a coordinating lifting and
placing response which was graded as follows: 0 = nor-
mal; 1 = weak; and 2 = no stepping [24]. Sensory function
was assessed by a hind limb withdrawal from a stimulus
(1 = withdrawal response to noxious stimulus applied to
hind limbs and 0 = no response to noxious stimulus). One
member of the research team who was blinded to the
treatment groups conducted all neurological tests.
Blood sampling and biochemical measurements
At the end of the experimental protocol period (48 hrs
after IRI), retro-orbital blood samples were obtained
through heparinized capillary tubes after overnight fast-
ing. Samples were added to EDTA and were centrifuged
at 1000 rpm for 15 min for separation of plasma and were
stored at -80°C to assay total plasma nitrite/nitrate (NOx)
level.
Estimation of plasma Nitrite/Nitrate (NOx)
The method for estimation of total nitrite/nitrate (NOx)
level was based on the Griess reaction. Plasma nitrite/
nitrate levels were measured after enzymatic conversion
of nitrate (NO3-) to nitrite (NO2-) by nitrate reductase in
the presence of NADPH. The oxidation of the coenzyme
was monitored by the decrease in absorbance at 540 nm.
Results were expressed as μmol/L [25].
Preparation of spinal cord homogenates
After completing the neurological assessment and
obtaining the blood samples, all rats were killed using the
lethal dose of thiopental sodium injection [22]. Sections
of the 3, 4, 5 lumbar segments of the spinal cord were har-
vested, dissected out, cute into small pieces and homoge-
nized using an Omni tissue homogenizer (Omni
international, Gainesville, VA, USA) [26]. Tissues were
homogenized in ice-cold lyses buffer [0.1 M phosphate,
pH 7.4, 1 mM EDTA, 10 μM indomethacin (Cayman
Chemical, Ann Arbor, MI, USA)] using a tube pestle.
Acetone was added (2 × sample volume), and samples
were centrifuged at 1500 × g for 10 min at 4°C. The
supernatants were then stored at -80°C [27].
Malondialdehyde (MDA),Advanced oxidation prod-
ucts (AOPP) levels, as well as SOD and CAT activities
in Spinal cord homogenate
Lipid peroxidation was assessed by the measurement of
secondary product MDA after precipitation of protein by
addition of trichloroacetic acid then thiobarbituric acid
(TBA) which reacted with MDA to form TBA reactive
product, which was measured at 532 nm. An MDA solu-
tion, freshly prepared by the hydrolysis of 1,1,3,3-tetram-
ethoxy propane was used as a standard [28].
Determination of advanced AOPP (with characteristic
absorbance at 340 nm) was based on spectrophotometric
method detection (Shimadzu Corporation, Kyoto, Japan,
UV- 160A) with tissue homogenate diluted with PBS to
0.2-0.5 g/ml [29]. SOD activity was assayed following the
method of Kakkar et al. [30]. The sample containing 5 μg
protein was mixed with sodium pyrophosphate buffer,
phenazine methosulphate (PMT) and nitro blue tetrazo-
lium (NBT). The reaction was started by the addition of
NADH, incubated at 30°C and stopped by the addition of
1 ml of glacial acetic acid. The absorbance of the chromo-
gen formed was measured at 560 nm. One unit of SOD
activity is defined, as the enzyme concentration required
to inhibit chromogen production by 50% in one minute
per mg protein under the assay condition. CAT activity
was measured in homogenate by the method of Bonaven-
tura et al. [31]. 5 μg proteins from the homogenate was
mixed with 2 ml of 7.5 mM H2O2 and a time scan was
performed for 10 min at 240 nm at 25°C. One unit of
CAT activity is defined as the amount of enzyme decom-
posing 1 μmol of H2O2 per minute per mg protein.
Spinal cord homogenate PGE2 determination
T i s s u e  l e v e l s  o f  P G E 2 in the spinal cord were assayed
using monoclonal enzyme immunoassay (EIA) kit. The
EIA kit demonstrates sensitivity from 10 to 1000 pg/ml
and demonstrates little cross reactivity between structur-
ally related PE3 and PE1. Absorbance (412 nm) values of
standards and samples were corrected by subtraction of
the background value to correct for absorbance caused by
nonspecific binding [32].
Chemicals
α-tocopherol was supplied by Sigma (St Louis, MO, USA)
that utilizes polyoxyl-35- Ricinusolle as an emulsifier;
ketamine hydrochloride was supplied by Pfizer Pharma-
ceutical Company, Inc, USA; thiopental sodium was sup-Morsy et al. Journal of Biomedical Science 2010, 17:55
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plied by Biocheme, Austria; heparin (Leo, Ballerup,
Denmark); Protamine sulfate (Leo, Ballerup, Denmark);
Prostaglandin E2  EIA kit and indomethacin (Cayman
Chemical, Ann Arbor, MI, USA) and nitrate reductase
from Aspergillus (Sigma).
Statistical analysis
Data were expressed as frequency, percentage and mean
± SD. Testing significance was performed using χ2 test
and the one-way analysis of variance (ANOVA). Post-hoc
Scheffe test was applied to identify the source of statisti-
cal significance. P-values < 0.05 were considered statisti-
cally significant.
Results
In control and sham groups, the administration of α-TOL
did not produce any significant changes in plasma nitrite/
nitrate or spinal cord homogenate of MDA, AOPP and
PGE2 levels, in addition to SOD activity and CAT activity.
However, in sham operated group PGE2 increased signifi-
cantly compared with the control groups (C, CE) (Fig. 1,
2, 3).
Plasma nitrite/nitrate level
Induction of IRI in rats produced significant elevation of
plasma nitrite/nitrate level (59.3 ± 4.5) compared with the
control groups [C (20 ± 1.3), CE (18.4 ± 1.4) and S (21.5 ±
1.5), (P < 0.001)]. On the other hand, i.m. administration
of α-TOL for 6 weeks resulted in significant reduction of
the plasma nitrite/nitrate level compared with IRI group
(33.2 ± 2.2) or control groups (P < 0.001) (Fig. 1).
Spinal cord homogenate levels of MDA, AOPP and PGE2
Lipid oxidative product MDA (7.1 ± 0.1), protein oxida-
tive product AOPP (7.7 ± 0.5) and inflammatory product
PGE2  (35.4 ± 2.1) levels in spinal cord homogenate
increased significantly in IRI group compared with the
control groups [C (3.4 ± 0.4), CE (4.0 ± 0.2) and S (19.3 ±
1.8), (P < 0.001)]. While administration of α-TOL pro-
duced significant reduction of the previously mentioned
parameters compared to the IRI group [(4.3 ± 0.4), (3.8 ±
0.2), (26.6 ± 1.4), p < 0.001] (Fig. 1, 2).
Spinal cord homogenate activity of SOD and CAT
Induction of IRI in rats resulted in significant elevation of
the SOD activity (15.1 ± 2.2) and significant reduction of
CAT activity (1.7 ± 0.3) in the spinal cord homogenate
compared with the control group [(7.6 ± 0.2) and (4.5 ±
0.8), respectively, p < 0.001 for both comparisons]. While,
i.m. administration of α-TOL produced a significant
reduction in SOD (8.1 ± 1.0) and a significant increase in
CAT (3.5 ± 0.4) activities compared with the IRI group (P
< 0.001 for both) (Fig. 1, 2).
Motor, SPR and sensory assessment
In the present study, rats in the IRI group showed acute
flaccid paraplegia of the hind limbs up to 6 hours after
reperfusion injury followed by spastic paraplegia. Their
motor score (mean ± SD) was 1.2 ± 1.0 compared with 4.8
± 0.4 in the control group. Also, sensory function was
impaired in 80% of rats in the IRI group, while SPR was
lost in 60% and was impaired in 20% of IRI rats. On the
other hand, α-TOL administration in IRIE group pro-
Figure 1 Effect of α-Tocopherol treatment for 6 weeks in ischemic reperfusion injury in rats. [a] Plasma level of nitrite/nitrate [b] Spinal cord 
homogenate levels of PGE2; . C: Control group; CE: α-Tocopherol control group; S: Sham group; IRI: Ischemic Reperfusion Injury group; IRIE: α-Tocoph-
erol-treated ischemic reperfusion injury group. Results are expressed as mean ± SD (n = 10). The groups which carries the "*" is significantly different 
from all other groups (P < 0.001).
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duced recovery of motor and sensory functions (3.8 ± 1.0
and 70%, respectively), while the SPR was recovered in
80% of IRIE rats (Table 1).
Discussion
Spinal cord injury is usually studied by electrophysiologi-
cal and histological methods. However, in order to assess
the degree of injury and recovery, functional evaluation is
crucial [5]. So, the current study was designed on rats
with spinal cord reperfusion injury model to evaluate
both motor and sensory deficits in addition to other labo-
ratory investigations. Improvement in these deficits was
also assessed after α-tocopherol administration.
Overproduction of ROS and free radicals is the possible
mechanism operating to modulate the patho-physiologi-
cal phenomenon associated with nervous system injury
Figure 2 Effect of α-Tocopherol treatment for 6 weeks in ischemic reperfusion injury in rats. Spinal cord homogenate levels of [a] MDA [b] 
AOPP. C: Control group; CE: α-Tocopherol control group; S: Sham group; IRI: Ischemic Reperfusion Injury group; IRIE: α-Tocopherol-treated ischemic 
reperfusion injury group. Results are expressed as mean ± SD (n = 10). The groups which carries the "*" is significantly different from all other groups 
(P < 0.001).
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Figure 3 Effect of α-Tocopherol treatment for 6 weeks in ischemic reperfusion injury in rats. Spinal cord homogenate activity levels of [a] SOD; 
[b] CAT. C: Control group; CE: α-Tocopherol control group; S: Sham group; IRI: Ischemic Reperfusion Injury group; IRIE: α-Tocopherol-treated ischemic 
reperfusion injury group. Results are expressed as mean ± SD (n = 10). The groups which carries the "*" is significantly different from all other groups 
(P < 0.001).
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[33]. The IRI group of rats in our study showed deteriora-
tion of motor function and lost placing stepping reflex
and impaired sensory function. This finding indicates
that induced vascular ischemia resulted in spinal cord
injury with subsequent disturbance of different neurolog-
ical functions [34].
In the present study, spinal cord homogenate MDA lev-
els, as a marker of lipid peroxidation and AOPP levels, as
a marker of protein oxidation, increased significantly in
the IRI group compared with the control groups (C, CE, S
groups with p < 0.001). The same effects have been
reported in spinal cord insults induced by chronic con-
striction injury of the sciatic nerve in rats [6]. The
increased generation of oxidative protein product is cor-
related with the degree of the produced free radicals [35].
Plasma levels of AOPP are also correlated with MDA and
pro-inflammatory cytokines levels, suggesting the role of
AOPP as a mediator in oxidative stress [36]. Antioxidant
enzymes, as SOD, form the primary defense against reac-
tive oxygen metabolites and have been shown to form an
important adaptive response to peroxidative stress [37].
In the present study, SOD increased while CAT enzyme
decreased significantly in spinal cord homogenate in IRI
rats. Similar results have been shown in neurological
injuries in series of researches due to oxidative stress and
inhibition of antioxidant defense potential [6]. The reduc-
tion of CAT activity may be responsible for a number of
deleterious effects in IRI due to the accumulation of H2O2
[38]. Severe reduction of antioxidants levels in nerve, spi-
nal cord and dorsal root ganglion in rat's neurological
injuries indicates high susceptibility of these tissues to
oxidative stress [6].
Our study demonstrated that NOx and PGE2 levels
increased significantly in the spinal cord homogenate
among the IRI group of rats. It was suggested that vascu-
lar neurological injuries induce iNOS activity with subse-
quent NO over-production leads to COX-2 activation
and PGE2  overproduction [39]. Consistent with this,
Nogawa et al. [40] found that COX-2 mRNA expression
in the brain peaked 12 hours after middle cerebral artery
occlusion; at a time when iNOS also reached peak expres-
sion as shown by the simultaneous elevation of both NOx
and PGE2 in the present work. Transient global ischemia
in gerbils results in a biphasic increase in COX activity
with an early increase in COX-1 activity and a delayed
persistent increase in COX-2 activity with subsequent
PGE2 overproduction [41]. It has been documented that
COX-2 and its product PGE2 participate in pathogenesis
of ischemic injury in the human brain [42].
Our results showed reduction of the lipid peroxidation
product "MDA", protein oxidation product "AOPP" and
Table 1: Effect of α-Tocopherol treatment in ischemic reperfusion injury model in rats for 6 weeks on Motor function, 
Sensory response and Placing/Stepping reflex scores
Test C CE S IRI IRIE p-value
Motor assessment Mean ± SD 4.8 ± 0.4(a) 4.8 ± 0.4(a) 4.0 ± 1.1(a) 1.2 ± 1.0(b) 3.8 ± 1.0(a) <0.001
Sensory assessment N o r m a l 89727
(80%)(a) (90%)(a) (70%)(a) (20%)(b) (70%)(a)
Affected 2 1 3 8 3 <0.05
(20%)(a) (10%)(a) (30%)(a) (80%)(b) (30%)(a)
Placing/Stepping reflex N o r m a l 89728
(80%)(a) (90%)(a) (70%)(a) (20%)(b) (80%)(a)
I m p a i r e d 21321 < 0 . 0 1
(20%)(a) (10%)(a) (30%)(a) (20%)(a) (10%)(a)
L o s t 00061
(0%)(a) (0%)(a) (0%)(a) (60%)(b) (10%)(a)
C: Control group; CE: α-Tocopherol control group; S: Sham group; IRI: Ischemic Reperfusion Injury group; IRIE: α-Tocopherol-treated ischemic 
reperfusion injury group. Results are expressed as mean ± SD (n = 10).
P value < 0.05 is considered significant.
Groups with different letters are statistically significant (p < 0.001)Morsy et al. Journal of Biomedical Science 2010, 17:55
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plasma NOx levels in the IRIE group, compared with the
control groups. Ziegler et al. stated that α-TOL is one of
the most potent biological antioxidants in the body tis-
sues that effectively protects against neuronal oxidative
stress damage. It interacts with free radicals and prevents
lipid peroxidation [43]. Clinically, α-TOL supplementa-
tion led to electrophysiological recovery of sensory con-
duction and evoked potentials in neurological vascular
insults [44]. Experimental studies showed that α-TOL
administration in animal's ischemic reperfusion injury
not only attenuates the oxidative injury of the muscle
cells but also reduces the formation of edema in these
cells. This may be due to the anti-inflammatory effect of
α-TOL by inhibiting PGE2 production [43]. The inhibi-
tory effect of α-TOL on PGE2 production in the presence
of abundant arachidonic acid, (the substrate for PGE2),
indicates that α-TOL mediates PGE2 inhibition mainly
through COX-2 inhibition rather than through substrate
release [45]. Wu et al. [46] showed that α-TOL exerts its
effect on COX activity and not on the downstream
enzyme PGE2 isomerase activity. They investigated the
effect of α-TOL on another COX product, thromboxane
A2 in the supernatant from COX activity cultures and
they did not find any effect of α-TOL on the isomerase
activity. As full activation of COX-2 enzyme requires the
presence of sufficient hydroperoxides [10]; α-TOL might
attenuate COX-2 activity by scavenging the oxidant
hydroperoxide and reducing the formation of peroxyni-
trite [18]. The fact that α-TOL inhibits COX-2 activity in
old mice supports this finding, as formation of lipid per-
oxides and NO increases in different tissues of the aged
animals [18]. Some investigators reported that NO stimu-
lates COX activity via direct stimulation of the enzyme
[47]. It is metabolized to peroxynitrite (ONOO) in the
presence of superoxide with subsequent induction of
COX activity without affecting its expression. α-TOL may
acts via other mechanisms than antioxidant activity
including cell signaling, interfering with other enzymatic
activity, apoptosis and modulating gene expression that
may contribute to its neuroprotective action [48].
Administration of α-TOL in IRI rats not only improves
the biochemical parameters measured but almost
restores the motor function, placing steeping reflex and
sensory responses to noxious stimuli up to the normal
control levels. This confirms that α-TOL not only
improves all aspects of oxidative stress injury and inflam-
matory responses of the spinal cord in IRI but also its
clinical neurological impacts [14]. Interruption of aortic
blood flow in IRI may not only induce spinal cord injury,
but also induce injury of the heart, gut, and kidney [41].
An additional mechanism that could be responsible for α-
TOL long-lasting neuro-protection of neurons against
oxidative stress; this was reported by Crouzin et al. who
found that, oxidative stress insults activates transient
receptor potential vanilloid 1 (TRPV1) channels which
one of the members of transient receptor potential (TRP)
family in neuronal tissues. Activation of these channels
mediate exaggerated Ca2+ influx with subsequent neu-
ronal death. α-TOL pretreatment in oxidative stress con-
ditions down-regulates TRPV1 channels activity [49]. In
addition, it has been found that the tocotrienol (TCT),
the subfamily of natural vitamin E, possesses powerful
neuroprotective activity. Nanomolar TCT significantly
attenuates the effects of glutamate on fatty acid levels and
on cytosolic phospholipase A2. Phospholipase A2 activa-
tion results in the release of free arachidonic acid within
the cell. Through the Src-Lox death pathway, arachidonic
acid overproduction results in the formation of 12-
hydroperoxyeicosatetraenoic acid which is lethal for cells
[50]. While our data showed a neuro-protective effect of
α-TOL in reducing the incidence of paraplegia, it may
exert further protective effects on other organs. So, more
investigations are required to prove or disprove this
hypothesis.
In conclusion, i.m. administration of the COX-2 inhibi-
tor α-TOL, at a dose of 600 mg twice weekly for six
weeks, significantly prevents the damage caused by spinal
cord ischemia in rats. Moreover, α-TOL improves motor
and sensory functions and reduces oxidative stress level.
Because spinal cord ischemia-induced paraplegia remains
a serious complication of IRI, prophylactic α-TOL admin-
istration might prove useful in its prevention. However,
extrapolating from rats to humans in this entity must be
done with caution, and testing with different doses and
therapy regimens in some other animal species remains
to be completed and thoroughly observed by safety trials
in humans before its clinical use.
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